These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32531450)

  • 1. Nanoparticles based on natural, engineered or synthetic proteins and polypeptides for drug delivery applications.
    Georgilis E; Abdelghani M; Pille J; Aydinlioglu E; van Hest JCM; Lecommandoux S; Garanger E
    Int J Pharm; 2020 Aug; 586():119537. PubMed ID: 32531450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Nanomedicines Based on Synthetic Polypeptides.
    Sun H; Gu X; Zhang Q; Xu H; Zhong Z; Deng C
    Biomacromolecules; 2019 Dec; 20(12):4299-4311. PubMed ID: 31659901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-responsive polypeptides for controlled drug delivery.
    Zhang P; Li M; Xiao C; Chen X
    Chem Commun (Camb); 2021 Sep; 57(75):9489-9503. PubMed ID: 34546261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
    Cabral H; Nishiyama N; Kataoka K
    Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unstructured polypeptides as a versatile drug delivery technology.
    Ji Y; Liu D; Zhu H; Bao L; Chang R; Gao X; Yin J
    Acta Biomater; 2023 Jul; 164():74-93. PubMed ID: 37075961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine-rich Proteins for Drug Delivery and Diagnosis.
    Yang G; Lu Y; Bomba HN; Gu Z
    Curr Med Chem; 2019; 26(8):1377-1388. PubMed ID: 28933301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
    Vangijzegem T; Stanicki D; Laurent S
    Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supramolecular Nanomedicine - An Overview.
    Sekhon BS
    Curr Drug Targets; 2015; 16(13):1407-28. PubMed ID: 25090984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-Assisted Nucleic Acid Delivery Systems on the Rise.
    Tarvirdipour S; Skowicki M; Schoenenberger CA; Palivan CG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems.
    van Elk M; Murphy BP; Eufrásio-da-Silva T; O'Reilly DP; Vermonden T; Hennink WE; Duffy GP; Ruiz-Hernández E
    Int J Pharm; 2016 Dec; 515(1-2):132-164. PubMed ID: 27725268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine-nanoscale drugs and delivery systems.
    Singh S
    J Nanosci Nanotechnol; 2010 Dec; 10(12):7906-18. PubMed ID: 21121278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.
    Yadav SC; Kumari A; Yadav R
    Peptides; 2011 Jan; 32(1):173-87. PubMed ID: 20934475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
    Soares AF; Carvalho Rde A; Veiga F
    Nanomedicine (Lond); 2007 Apr; 2(2):183-202. PubMed ID: 17716120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Design of Nanocarriers for Intracellular Protein Delivery.
    Qin X; Yu C; Wei J; Li L; Zhang C; Wu Q; Liu J; Yao SQ; Huang W
    Adv Mater; 2019 Nov; 31(46):e1902791. PubMed ID: 31496027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastin-Like Recombinamers As Smart Drug Delivery Systems.
    Arias FJ; Santos M; Ibanez-Fonseca A; Pina MJ; Serrano S
    Curr Drug Targets; 2018 Feb; 19(4):360-379. PubMed ID: 26844559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.